News

Published on 26 Nov 2022 on Simply Wall St. via Yahoo Finance

Despite currently being unprofitable, Glaukos (NYSE:GKOS) has delivered a 79% return to shareholders...


Article preview image

Glaukos Corporation (NYSE:GKOS) shareholders have seen the share price descend 16% over the month. On the bright side the returns have been quite good over the last half decade. It has returned a market beating 79% in that time.

In light of the stock dropping 3.6% in the past week, we want to investigate the longer term story, and see if fundamentals have been the driver of the company's positive five-year return.

See our latest analysis for Glaukos

NYSE.GKOS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Here's Why You Should Retain Glaukos (GKOS) Stock for Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial result...

Zacks via Yahoo Finance 15 Apr 2024

Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally?

Glaukos GKOS is witnessing strong momentum, with its shares having rallied 24.8% year to date com...

Zacks via Yahoo Finance 12 Apr 2024

Is Now The Time To Look At Buying Glaukos Corporation (NYSE:GKOS)?

While Glaukos Corporation (NYSE:GKOS) might not have the largest market cap around , it received ...

Simply Wall St. via Yahoo Finance 11 Apr 2024

Glaukos (GKOS) Hits 52-Week High: What's Driving the Stock?

Shares of Glaukos Corporation GKOS scaled a new 52-week high of $97.77 on Apr 5, before closing t...

Zacks via Yahoo Finance 8 Apr 2024

Glaukos (GKOS) Down 4.3% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for Glaukos (GKOS). Shares have lost about 4.3...

Zacks via Yahoo Finance 22 Mar 2024

Here's Why You Should Retain Glaukos (GKOS) Stock for Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial result...

Zacks via Yahoo Finance 13 Mar 2024

Celanese (CE) Announces Commercial Launch of Glaukos' iDose TR

Celanese Corporation CE recently announced the launch of Glaukos Corporation's iDose TR. This use...

Zacks via Yahoo Finance 4 Mar 2024

Glaukos (GKOS) Q4 Earnings Miss Estimates, Revenues Rise Y/Y

Glaukos Corporation GKOS reported a fourth-quarter 2023 adjusted loss of 63 cents per share, 12.5...

Zacks via Yahoo Finance 22 Feb 2024

Glaukos Corporation (NYSE:GKOS) Q4 2023 Earnings Call Transcript

Glaukos Corporation (NYSE:GKOS) Q4 2023 Earnings Call Transcript February 21, 2024 Glaukos Corpor...

Insider Monkey via Yahoo Finance 22 Feb 2024

Is Glaukos Corporation (NYSE:GKOS) Trading At A 41% Discount?

Key Insights Glaukos' estimated fair value is US$155 based on 2 Stage Free Cash Flow to EquityGla...

Simply Wall St. via Yahoo Finance 21 Feb 2024